NovaQuest Capital Management, located in North Carolina’s Research Triangle, is a life science investment firm with a specialization in biopharmaceuticals. Founded in 2010, and with more than $2.5 billion raised across multiple asset classes, NovaQuest provides tailored capital solutions that fund innovation in biopharmaceutical development and invests in compelling healthcare companies with products and technologies aimed at helping humans and animals live healthier, longer, more productive lives.
NovaQuest Capital Management has a long and proven history of life sciences investing.
NovaQuest forms as a strategic investment arm within Quintiles Transnational (now IQVIA), laying the foundation for the firm’s product finance and private equity strategies
Investing at Quintiles Transnational
NovaQuest invests over $1 billion across life sciences, pharmaceutical services, and technology
An Independent Firm
NovaQuest Capital becomes an independent firm, spinning out from Quintiles Transnational (IQVIA) to continue its investment strategy
Product Finance Fund III
NovaQuest Capital raises its first institutional fund with approximately $500 million in capital
Product Finance Fund IV
NovaQuest Capital raises approximately $900 million in capital
NovaQuest Capital formalizes separate Private Equity strategy and expands the investment team
Product Finance Fund V & Private Equity Fund I
NovaQuest Capital raises approximately $1.2 billion for Product Finance Fund V and $275 million for Private Equity Fund I
Animal Health Expansion
NovaQuest expands its strategy to bring much needed capital in the animal health industry by closing its first animal health transactions.